Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Bellerophon Therapeutics, Inc. | Director | Stock Options (Right to Buy) | 14.6K | $45.3K | $3.10 | Jun 7, 2023 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
BLPH | Bellerophon Therapeutics, Inc. | Jun 7, 2023 | 1 | $0 | 4 | Jun 9, 2023 | Director |
BLPH | Bellerophon Therapeutics, Inc. | Feb 10, 2023 | 1 | $44.1K | 4 | Feb 14, 2023 | Director |
BLPH | Bellerophon Therapeutics, Inc. | Dec 31, 2021 | 1 | $67.7K | 4 | Jan 4, 2022 | Director |